CRITIPAN INJ 40MG 40MG –

The Brand Name CRITIPAN INJ 40MG Has Generic Salt :: –  CRITIPAN INJ 40MG  Is From Company AMRA REM Priced :: Rs. 60 CRITIPAN INJ 40MG have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt...

CRITIPAC 260 1 –

The Brand Name CRITIPAC 260 Has Generic Salt :: –  CRITIPAC 260  Is From Company AMRA REM Priced :: Rs. 9900 CRITIPAC 260 have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR...

CRITIPAC 100 1 –

The Brand Name CRITIPAC 100 Has Generic Salt :: –  CRITIPAC 100  Is From Company AMRA REM Priced :: Rs. 4199 CRITIPAC 100 have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR...

CRITINIB 400 10 –

The Brand Name CRITINIB 400 Has Generic Salt :: –  CRITINIB 400  Is From Company AMRA REM Priced :: Rs. 3650 CRITINIB 400 have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR...

CRITINIB 100 10 –

The Brand Name CRITINIB 100 Has Generic Salt :: –  CRITINIB 100  Is From Company AMRA REM Priced :: Rs. 950 CRITINIB 100 have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR...

CRITIDOC 20 1 –

The Brand Name CRITIDOC 20 Has Generic Salt :: –  CRITIDOC 20  Is From Company AMRA REM Priced :: Rs. 3350 CRITIDOC 20 have – is comes under Sub class #N/A of  Main Class #N/A Main Medicine Class:: #N/A  Sub Medicine Class :: #N/A   Salt Name :  OR Generic...

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline